Metabolism of nicotine and cotinine by human cytochrome P450 2A13

Drug Metabolism and Disposition

Volumn 33, Issue 2, 2005, Pages 258-261

  Bao, Ziping ^a   He, Xiao Yang ^a   Ding, Xinxin ^b   Prabhu, Saileta ^a   Hong, Jun Yan ^a,c  

^a RUTGERS UNIVERSITY   (United States)

^b WADSWORTH CENTER   (United States)

^c UNIVERSITY OF MEDICINE AND DENTISTRY OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3' HYDROXYCOTININE; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANOL; CARCINOGEN; COTININE; CYTOCHROME P450 2A13; CYTOCHROME P450 ISOENZYME; NICOTINE; NITROSONORNICOTINE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; DRUG DEPENDENCE; ENZYME SUBSTRATE; HYDROXYLATION; KINETICS; METABOLITE; OXIDATION; PRIORITY JOURNAL; SMOKING; XENOBIOTIC METABOLISM;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CARCINOGENS; COTININE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INSECTS; MICROSOMES; NICOTINE; NITROSAMINES; SUBSTRATE SPECIFICITY;

NICOTIANA TABACUM;

EID: 13444274285     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: 10.1124/dmd.104.002105     Document Type: Article

References (27)

1. Benowitz NL, Lake T, Keller KH, and Lee BL (1987) Prolonged absorption with development of tolerance to toxic effects after cutaneous exposure to nicotine. Clin Pharmacol Ther 42:119-120.
2. Fernandez-Salguero P and Gonzalez FJ (1995) The CYP2A gene subfamily: species differences, regulation, catalytic activities and role in chemical carcinogenesis. Pharmacogenetics 5:S123-S128.
3. Flammang AM, Gelboin HV, Aoyama T, Gonzalez FJ, and McCoy GD (1992) Nicotine metabolism by cDNA-expressed human cytochrome P-450s. Biochem Arch 8:1-8.
4. Gorrod JW and Hibberd AR (1982) The metabolism of nicotine-delta 1′(5′)-iminium ion, in vivo and in vitro. Eur J Drug Metab Pharmacokinet 7:293-298.
5. Henningfield JE, Miyasato K, and Jasinski DR (1985) Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234:1-12.
6. Heusch WL and Maneckjee R (1998) Signalling pathways involved in nicotine regulation of apoptosis of human lung cancer cells. Carcinogenesis 19:551-556.
7. Hong JY, Wang ZY, Smith TJ, Zhou S, Shi S, Pan J, and Yang CS (1992) Inhibitory effects of diallyl sulfide on the metabolism and tumorigenicity of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in A/J mouse lung. Carcinogenesis 13:901-904.
8. Jacob P 3rd, Benowitz NL, and Shulgin AT (1988) Recent studies of nicotine metabolism in humans. Pharmacol Biochem Behav 30:249-253.
9. Jacob P 3rd, Shulgin AT, and Benowitz NL (1990) Synthesis of (3′R,5′S)-trans-3′ hydroxycotinine, a major metabolite of nicotine. Metabolic formation of 3′-hydroxycotinine in humans is highly stereoselective. J Med Chem 33:1888-1891.
10. Kitagawa K, Kunugita N, Katoh T, Yang M, and Kawamoto T (1999) The significance of the homozygous CYP2A6 deletion on nicotine metabolism: a new genotyping method of CYP2A6 using a single PCR-RFLP. Biochem Biophys Res Commun 262:146-151.
11. Koskela S, Hakkola J, Hukkanen J, Pelkonen O, Sorri M, Saranen A, Anttila S, Fernandez-Salguero P, Gonzalez F, and Raunio H (1999) Expression of CYP2A genes in human liver and extrahepatic tissues. Biochem Pharmacol 57:1407-1413.
12. McCracken NW, Cholerton S, and Idle JR (1992) Cotinine formation by cDNA-expressed human cytochromes P450. Med Sci Res 20:877-878.
13. Messina ES, Tyndale RF, and Sellers EM (1997) A major role for CYP2A6 in nicotine C-oxidation by human liver microsomes. J Pharmacol Exp Ther 282:1608-1614.
14. Murphy SE, Johnson LM, and Pullo DA (1999) Characterization of multiple products of cytochrome P450 2A6-catalyzed cotinine metabolism. Chem Res Toxicol 12:639-645.
15. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, and Kuroiwa Y (1996a) Role of human cytochrome P4502A6 in C-oxidation of nicotine. Drug Metab Dispos 24:1212-1217.
16. Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, and Kuroiwa Y (1996b) Characterization of CYP2A6 involved in 3′-hydroxylation of cotinine in human liver microsomes. J Pharmacol Exp Ther 277:1010-1015.
17. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. J Biol Chem 239:2379-2385.
18. Pelkonen O and Raunio H (1995) Individual expression of carcinogen-metabolizing enzymes: cytochrome P4502A. J Occup Environ Med 37:19-24.
19. Pelkonen O, Rautio A, Raunio H, and Pasanen M (2000) CYP2A6: a human coumarin 7-hydroxylase. Toxicology 144:139-147.
20. Peterson LA, Trevor A, and Castagnoli N Jr (1987) Stereochemical studies on the cytochrome P-450 catalyzed oxidation of (S)-nicotine to the (S)-nicotine delta 1′(5′)-iminium species. J Med Chem 30:249-254.
21. Plummer HK 3rd, Sheppard BJ, and Schuller HM (2000) Interaction of tobacco-specific toxicants with nicotinic cholinergic regulation of fetal pulmonary neuroendocrine cells: implications for pediatric lung disease. Exp Lung Res 26:121-135.
22. Schuller HM, Jull BA, Sheppard BJ, and Plummer HK (2000) Interaction of tobacco-specific toxicants with the neuronal alpha(7) nicotinic acetylcholine receptor and its associated mitogenic signal transduction pathway: potential role in lung carcinogenesis and pediatric lung disorders. Eur J Pharmacol 393:265-277.
23. Shimada T, Yamazaki H, Mimura M, Wakamiya N, Ueng YF, Guengerich FP, and Inui Y (1996) Characterization of microsomal cytochrome P450 enzymes involved in the oxidation of xenobiotic chemicals in human fetal liver and adult lungs. Drug Metab Dispos 24:515-522.
24. Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, and Ding X (2000) Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res 60:5074-5079.
25. Wang H, Tan W, Hao B, Miao X, Zhou G, He F, and Lin D (2003) Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res 63:8057-8061.
26. Williams DE, Shigenaga MK, and Castagnoli N Jr (1990) The role of cytochromes P-450 and flavin-containing monooxygenase in the metabolism of (S)-nicotine by rabbit lung. Drug Metab Dispos 18:418-428.
27. Yasukochi Y and Masters BS (1976) Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography. J Biol Chem 251:5337-5344.